C. elegans is a useful model to investigate pathways involved in the maintenance of long term cellular arrest. In unfavorable conditions, C. elegans larvae enter a long-lived state, known as dauer, in which cells remain quiescent and multipotent for a prolonged period of time. The Vulval Precursor Cell (VPC) specification paradigm is a tractable context to study these blocks to differentiation and division in dauer larvae. In continuous development, an EGF signal sent from the gonad activates the Epidermal Growth Factor Receptor (EGFR) and its canonical signal transduction cascade (Ras-Raf-MEK-ERK) in the nearest VPC, P6.p. ERK activity in this cell leads to gene expression associated with 1 deg vulval fate, including the expression of
lag-2, a lateral signal that activates LIN-12/Notch in the two neighboring VPCs, causing them to adopt the 2 deg vulval fate. Cells that take on 1 deg or 2 deg fate will divide and generate descendants that form the structures of the vulva. When animals enter dauer, the VPCs become reprogrammed to a multipotent, unspecified state and appear to experience an active block to EGFR signal transduction and specification of cell fates (Euling and Ambros, 1996; Karp and Greenwald 2013). Transcriptional reporters for target genes of the EGFR pathway are silenced in dauer larvae (Karp and Greenwald 2013) but do not provide information on whether EGFR signal transduction is blocked or if transcription is opposed downstream of ERK at the level of the target gene. We have now used the ERK-nKTR, a fluorescently tagged biosensor that allows for quantification of ERK activity in individual VPCs (de la Cova et al. 2017), to show that EGFR pathway signal transduction per se is blocked in dauers formed by starvation on plates or constitutive dauers formed by mutation in
daf-7/TGF?. We examined constitutively activated forms of LET-60/Ras or LET-45/Raf and found that ERK activation was restored, suggesting that the block occurs at the level of Ras or upstream of the canonical cascade. We are continuing to use genetic and transgenic methods to elucidate the step at which EGFR signal transduction is negatively regulated during dauer, and will then investigate the mechanism by which this block is conferred.